Cotter, L., Rae, M., McGough, M., Panchal, N., Wager, E., Cox, C., & Claxton, G
The key finding was that 75% of weight lost was fat and 25% was lean tissue, a ratio that confirms tirzepatide is not simply causing indiscriminate weight loss but preferentially targeting visceral and subcutaneous fat
This targeted mechanism allows enhanced fat oxidation and reduced lipogenesis, particularly in visceral and abdominal fat depots, making it a key subject in obesity and metabolic optimization research
Frequently Asked Questions Expert-Guided, Sustainable Weight Loss Discover how proven medications such as semaglutide or tirzepatide, combined with expert support, can help you reach lasting weight loss results.
79 GastaldelliACusiKFernndez LandLBrayRBrouwersBRodrguez